Chad McClintock
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chad McClintock has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Jordan Miller
School of Rehabilitation Therapy, Queen’s University, Kingston, Canada
5 shared publications - Joy Christine MacDermid
From the: School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
5 shared publications - Kevin Varette
School of Rehabilitation Therapy, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
5 shared publications - Catherine Donnelly
School of Rehabilitation Therapy, Queen’s University, Kingston, Canada
4 shared publications - David Barber
Department of Family Medicine, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
4 shared publications - Geneviève Bacchus
School of Rehabilitation Therapy, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
4 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89006
Determining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial With Process Evaluation
Background: Hip and knee pain are leading contributors to disability, reduced quality of life, and health care burden in Canada. Primary care is often the first point of contact for patients with these conditions, yet timely and appropriate care is limited due to provider shortages and system pressures. Interest is growing in interprofessional primary care models that integrate physiotherapists to enhance care delivery for musculoskeletal conditions such as hip and knee pain. Objective: This study aims to communicate the protocol and analysis plan for a trial with two objectives: (1) to evaluate the effectiveness of a physiotherapist-led primary care model for hip and knee pain on physical functioning (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events, compared to usual physician-led primary care; and (2) to assess the impact of this model on health care system and societal outcomes, including access to care, health care use, productivity loss, and cost-effectiveness. A process evaluation will examine implementation, potential mechanisms, and patient experiences. Methods: A cluster randomized controlled trial involving 14 primary care organizations randomized equally to either a physiotherapist-led or usual physician-led primary care model for patients with hip and knee pain. Patients were recruited over 1 year, with data collected at baseline and at 3, 6, 9, and 12 months. The intervention integrates a physiotherapist as the initial point of contact within the primary care team for patients seeking care for hip or knee pain. It includes four components: (1) comprehensive assessment and screening, (2) brief individualized interventions during the initial visit, (3) guidance for accessing additional health care resources, and (4) follow-up physiotherapy for patients with unmet needs. Effectiveness will be assessed using linear mixed regression, accounting for clusters and prespecified covariates. The multimethods process evaluation will include descriptive and comparative analysis of implementation, mediation analysis to explore potential mechanisms, and qualitative exploration of patient experiences. Results: This research was funded in December 2022. Primary care sites (clusters) were recruited and randomized in June and July 2023, respectively. Patient enrollment occurred from October 2023 through November 2024. The final patient follow-up survey was completed in November 2025. Extraction of data from electronic health records is expected to finish in December 2025. Data analysis will begin after data collection is complete and will follow the predefined protocol and analysis plan. No interim analyses are planned. Conclusions: Findings from this trial will provide actionable evidence on whether integrating physiotherapists into primary care teams for hip and knee pain improves patient outcomes and health care system efficiency. Effectiveness and process evaluation evidence will inform policymakers and health system leaders on the adoption and implementation of interprofessional, team-based primary care models. Trial Registration: ClinicalTrials.gov NCT06358521; https://clinicaltrials.gov/study/NCT06358521 International Registered Report Identifier (IRRID): DERR1-10.2196/89006
- 22 May 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89006
Open AccessDetermining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial With Process Evaluation
Background: Hip and knee pain are leading contributors to disability, reduced quality of life, and health care burden in Canada. Primary care is often the first point of contact for patients with these conditions, yet timely and appropriate care is limited due to provider shortages and system pressures. Interest is growing in interprofessional primary care models that integrate physiotherapists to enhance care delivery for musculoskeletal conditions such as hip and knee pain. Objective: This study aims to communicate the protocol and analysis plan for a trial with two objectives: (1) to evaluate the effectiveness of a physiotherapist-led primary care model for hip and knee pain on physical functioning (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events, compared to usual physician-led primary care; and (2) to assess the impact of this model on health care system and societal outcomes, including access to care, health care use, productivity loss, and cost-effectiveness. A process evaluation will examine implementation, potential mechanisms, and patient experiences. Methods: A cluster randomized controlled trial involving 14 primary care organizations randomized equally to either a physiotherapist-led or usual physician-led primary care model for patients with hip and knee pain. Patients were recruited over 1 year, with data collected at baseline and at 3, 6, 9, and 12 months. The intervention integrates a physiotherapist as the initial point of contact within the primary care team for patients seeking care for hip or knee pain. It includes four components: (1) comprehensive assessment and screening, (2) brief individualized interventions during the initial visit, (3) guidance for accessing additional health care resources, and (4) follow-up physiotherapy for patients with unmet needs. Effectiveness will be assessed using linear mixed regression, accounting for clusters and prespecified covariates. The multimethods process evaluation will include descriptive and comparative analysis of implementation, mediation analysis to explore potential mechanisms, and qualitative exploration of patient experiences. Results: This research was funded in December 2022. Primary care sites (clusters) were recruited and randomized in June and July 2023, respectively. Patient enrollment occurred from October 2023 through November 2024. The final patient follow-up survey was completed in November 2025. Extraction of data from electronic health records is expected to finish in December 2025. Data analysis will begin after data collection is complete and will follow the predefined protocol and analysis plan. No interim analyses are planned. Conclusions: Findings from this trial will provide actionable evidence on whether integrating physiotherapists into primary care teams for hip and knee pain improves patient outcomes and health care system efficiency. Effectiveness and process evaluation evidence will inform policymakers and health system leaders on the adoption and implementation of interprofessional, team-based primary care models. Trial Registration: ClinicalTrials.gov NCT06358521; https://clinicaltrials.gov/study/NCT06358521 International Registered Report Identifier (IRRID): DERR1-10.2196/89006
- Open Access
- 26 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89004
Determining the Impact of a Physiotherapist-Led Primary Care Model for Low Back Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial and Embedded Process Evaluation
Background: Low back pain (LBP) is a common and disabling condition that is costly for health systems and society. Interprofessional primary care models may improve care quality and reduce this burden. Objective: This protocol and analysis plan communicates the methods for a cluster randomized trial with the following objectives: (1) evaluate the effectiveness of a physiotherapist-led (PT-led) primary care model for LBP at improving disability (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events compared with usual physician-led primary care; and (2) determine the impact of the PT-led primary care model for LBP on the health care system and society (health care access, health care use, missed work, cost-effectiveness). Both objectives are evaluated over a 1-year period. A multimethod process evaluation is embedded to assess model implementation, mechanisms, perspectives of patients and providers, and contextual influences. Methods: This study is a cluster randomized controlled trial with 20 primary care practices (clusters) in Canada, randomized 1:1 to a PT-led or usual physician-led primary care model for LBP. Adults seeking care from their primary care team for LBP are recruited over 1 year. Data collection occurs at baseline, 6 weeks, and 3, 6, 9, and 12 months. Effectiveness will be analyzed using linear mixed regression. The process evaluation analysis will include: descriptive and comparative analyses to assess implementation; descriptive and mediation analyses to assess potential mechanisms; qualitative interpretive description to understand experiences and perspectives of patients, PTs, and other health professionals; and mixed methods to determine contextual influences on implementation. Results: Recruitment of primary care sites (clusters) was completed in June 2023, following delays related to the COVID-19 pandemic. Cluster randomization occurred in July 2023. Recruitment of patient participants began in October 2023 and concluded in November 2024 (n=739). The final self-reported patient data was collected on November 25, 2025. Extraction of electronic health record data is scheduled for completion on December 19, 2025. Data analysis will be conducted in accordance with the study protocol and analysis plan and will begin once all data collection activities are complete. No interim analyses have been performed. Conclusions: The results of this trial will provide evidence for knowledge users to determine whether a PT-led primary care model for LBP is effective and should be adopted more widely. Knowledge users have identified the impact of the new model of care on disability, quality of life, and cost-effectiveness as key evidence needed to inform key decision-making. The multimethod process evaluation will provide critical evidence to interpret trial results and inform future scale and spread of this model of care if effective. Trial Registration: ClinicalTrials.gov NCT04287413; https://clinicaltrials.gov/study/NCT04287413 International Registered Report Identifier (IRRID): DERR1-10.2196/89004
- 26 February 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e89004
Open AccessDetermining the Impact of a Physiotherapist-Led Primary Care Model for Low Back Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial and Embedded Process Evaluation
Background: Low back pain (LBP) is a common and disabling condition that is costly for health systems and society. Interprofessional primary care models may improve care quality and reduce this burden. Objective: This protocol and analysis plan communicates the methods for a cluster randomized trial with the following objectives: (1) evaluate the effectiveness of a physiotherapist-led (PT-led) primary care model for LBP at improving disability (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events compared with usual physician-led primary care; and (2) determine the impact of the PT-led primary care model for LBP on the health care system and society (health care access, health care use, missed work, cost-effectiveness). Both objectives are evaluated over a 1-year period. A multimethod process evaluation is embedded to assess model implementation, mechanisms, perspectives of patients and providers, and contextual influences. Methods: This study is a cluster randomized controlled trial with 20 primary care practices (clusters) in Canada, randomized 1:1 to a PT-led or usual physician-led primary care model for LBP. Adults seeking care from their primary care team for LBP are recruited over 1 year. Data collection occurs at baseline, 6 weeks, and 3, 6, 9, and 12 months. Effectiveness will be analyzed using linear mixed regression. The process evaluation analysis will include: descriptive and comparative analyses to assess implementation; descriptive and mediation analyses to assess potential mechanisms; qualitative interpretive description to understand experiences and perspectives of patients, PTs, and other health professionals; and mixed methods to determine contextual influences on implementation. Results: Recruitment of primary care sites (clusters) was completed in June 2023, following delays related to the COVID-19 pandemic. Cluster randomization occurred in July 2023. Recruitment of patient participants began in October 2023 and concluded in November 2024 (n=739). The final self-reported patient data was collected on November 25, 2025. Extraction of electronic health record data is scheduled for completion on December 19, 2025. Data analysis will be conducted in accordance with the study protocol and analysis plan and will begin once all data collection activities are complete. No interim analyses have been performed. Conclusions: The results of this trial will provide evidence for knowledge users to determine whether a PT-led primary care model for LBP is effective and should be adopted more widely. Knowledge users have identified the impact of the new model of care on disability, quality of life, and cost-effectiveness as key evidence needed to inform key decision-making. The multimethod process evaluation will provide critical evidence to interpret trial results and inform future scale and spread of this model of care if effective. Trial Registration: ClinicalTrials.gov NCT04287413; https://clinicaltrials.gov/study/NCT04287413 International Registered Report Identifier (IRRID): DERR1-10.2196/89004
- Open Access
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Determining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial With Process Evaluation (Preprint)
BACKGROUND Hip and knee pain are leading contributors to disability, reduced quality of life, and health care burden in Canada. Primary care is often the first point of contact for patients with these conditions, yet timely and appropriate care is limited due to provider shortages and system pressures. Interest is growing in interprofessional primary care models that integrate physiotherapists to enhance care delivery for musculoskeletal conditions such as hip and knee pain. OBJECTIVE This study aims to communicate the protocol and analysis plan for a trial with two objectives: (1) to evaluate the effectiveness of a physiotherapist-led primary care model for hip and knee pain on physical functioning (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events, compared to usual physician-led primary care; and (2) to assess the impact of this model on health care system and societal outcomes, including access to care, health care use, productivity loss, and cost-effectiveness. A process evaluation will examine implementation, potential mechanisms, and patient experiences. METHODS A cluster randomized controlled trial involving 14 primary care organizations randomized equally to either a physiotherapist-led or usual physician-led primary care model for patients with hip and knee pain. Patients were recruited over 1 year, with data collected at baseline and at 3, 6, 9, and 12 months. The intervention integrates a physiotherapist as the initial point of contact within the primary care team for patients seeking care for hip or knee pain. It includes four components: (1) comprehensive assessment and screening, (2) brief individualized interventions during the initial visit, (3) guidance for accessing additional health care resources, and (4) follow-up physiotherapy for patients with unmet needs. Effectiveness will be assessed using linear mixed regression, accounting for clusters and prespecified covariates. The multimethods process evaluation will include descriptive and comparative analysis of implementation, mediation analysis to explore potential mechanisms, and qualitative exploration of patient experiences. RESULTS This research was funded in December 2022. Primary care sites (clusters) were recruited and randomized in June and July 2023, respectively. Patient enrollment occurred from October 2023 through November 2024. The final patient follow-up survey was completed in November 2025. Extraction of data from electronic health records is expected to finish in December 2025. Data analysis will begin after data collection is complete and will follow the predefined protocol and analysis plan. No interim analyses are planned. CONCLUSIONS Findings from this trial will provide actionable evidence on whether integrating physiotherapists into primary care teams for hip and knee pain improves patient outcomes and health care system efficiency. Effectiveness and process evaluation evidence will inform policymakers and health system leaders on the adoption and implementation of interprofessional, team-based primary care models. CLINICALTRIAL ClinicalTrials.gov NCT06358521; https://clinicaltrials.gov/study/NCT06358521 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/89006
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDetermining the Impact of a Physiotherapist-Led Primary Care Model for Hip and Knee Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial With Process Evaluation (Preprint)
BACKGROUND Hip and knee pain are leading contributors to disability, reduced quality of life, and health care burden in Canada. Primary care is often the first point of contact for patients with these conditions, yet timely and appropriate care is limited due to provider shortages and system pressures. Interest is growing in interprofessional primary care models that integrate physiotherapists to enhance care delivery for musculoskeletal conditions such as hip and knee pain. OBJECTIVE This study aims to communicate the protocol and analysis plan for a trial with two objectives: (1) to evaluate the effectiveness of a physiotherapist-led primary care model for hip and knee pain on physical functioning (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events, compared to usual physician-led primary care; and (2) to assess the impact of this model on health care system and societal outcomes, including access to care, health care use, productivity loss, and cost-effectiveness. A process evaluation will examine implementation, potential mechanisms, and patient experiences. METHODS A cluster randomized controlled trial involving 14 primary care organizations randomized equally to either a physiotherapist-led or usual physician-led primary care model for patients with hip and knee pain. Patients were recruited over 1 year, with data collected at baseline and at 3, 6, 9, and 12 months. The intervention integrates a physiotherapist as the initial point of contact within the primary care team for patients seeking care for hip or knee pain. It includes four components: (1) comprehensive assessment and screening, (2) brief individualized interventions during the initial visit, (3) guidance for accessing additional health care resources, and (4) follow-up physiotherapy for patients with unmet needs. Effectiveness will be assessed using linear mixed regression, accounting for clusters and prespecified covariates. The multimethods process evaluation will include descriptive and comparative analysis of implementation, mediation analysis to explore potential mechanisms, and qualitative exploration of patient experiences. RESULTS This research was funded in December 2022. Primary care sites (clusters) were recruited and randomized in June and July 2023, respectively. Patient enrollment occurred from October 2023 through November 2024. The final patient follow-up survey was completed in November 2025. Extraction of data from electronic health records is expected to finish in December 2025. Data analysis will begin after data collection is complete and will follow the predefined protocol and analysis plan. No interim analyses are planned. CONCLUSIONS Findings from this trial will provide actionable evidence on whether integrating physiotherapists into primary care teams for hip and knee pain improves patient outcomes and health care system efficiency. Effectiveness and process evaluation evidence will inform policymakers and health system leaders on the adoption and implementation of interprofessional, team-based primary care models. CLINICALTRIAL ClinicalTrials.gov NCT06358521; https://clinicaltrials.gov/study/NCT06358521 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/89006
- Open Access
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Determining the Impact of a Physiotherapist-Led Primary Care Model for Low Back Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial and Embedded Process Evaluation (Preprint)
BACKGROUND Low back pain (LBP) is a common and disabling condition that is costly for health systems and society. Interprofessional primary care models may improve care quality and reduce this burden. OBJECTIVE This protocol and analysis plan communicates the methods for a cluster randomized trial with the following objectives: (1) evaluate the effectiveness of a physiotherapist-led (PT-led) primary care model for LBP at improving disability (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events compared with usual physician-led primary care; and (2) determine the impact of the PT-led primary care model for LBP on the health care system and society (health care access, health care use, missed work, cost-effectiveness). Both objectives are evaluated over a 1-year period. A multimethod process evaluation is embedded to assess model implementation, mechanisms, perspectives of patients and providers, and contextual influences. METHODS This study is a cluster randomized controlled trial with 20 primary care practices (clusters) in Canada, randomized 1:1 to a PT-led or usual physician-led primary care model for LBP. Adults seeking care from their primary care team for LBP are recruited over 1 year. Data collection occurs at baseline, 6 weeks, and 3, 6, 9, and 12 months. Effectiveness will be analyzed using linear mixed regression. The process evaluation analysis will include: descriptive and comparative analyses to assess implementation; descriptive and mediation analyses to assess potential mechanisms; qualitative interpretive description to understand experiences and perspectives of patients, PTs, and other health professionals; and mixed methods to determine contextual influences on implementation. RESULTS Recruitment of primary care sites (clusters) was completed in June 2023, following delays related to the COVID-19 pandemic. Cluster randomization occurred in July 2023. Recruitment of patient participants began in October 2023 and concluded in November 2024 (n=739). The final self-reported patient data was collected on November 25, 2025. Extraction of electronic health record data is scheduled for completion on December 19, 2025. Data analysis will be conducted in accordance with the study protocol and analysis plan and will begin once all data collection activities are complete. No interim analyses have been performed. CONCLUSIONS The results of this trial will provide evidence for knowledge users to determine whether a PT-led primary care model for LBP is effective and should be adopted more widely. Knowledge users have identified the impact of the new model of care on disability, quality of life, and cost-effectiveness as key evidence needed to inform key decision-making. The multimethod process evaluation will provide critical evidence to interpret trial results and inform future scale and spread of this model of care if effective. CLINICALTRIAL ClinicalTrials.gov NCT04287413; https://clinicaltrials.gov/study/NCT04287413 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/89004
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDetermining the Impact of a Physiotherapist-Led Primary Care Model for Low Back Pain: Protocol and Analysis Plan for a Cluster Randomized Controlled Trial and Embedded Process Evaluation (Preprint)
BACKGROUND Low back pain (LBP) is a common and disabling condition that is costly for health systems and society. Interprofessional primary care models may improve care quality and reduce this burden. OBJECTIVE This protocol and analysis plan communicates the methods for a cluster randomized trial with the following objectives: (1) evaluate the effectiveness of a physiotherapist-led (PT-led) primary care model for LBP at improving disability (primary outcome), pain intensity, quality of life, global rating of change, patient satisfaction, and adverse events compared with usual physician-led primary care; and (2) determine the impact of the PT-led primary care model for LBP on the health care system and society (health care access, health care use, missed work, cost-effectiveness). Both objectives are evaluated over a 1-year period. A multimethod process evaluation is embedded to assess model implementation, mechanisms, perspectives of patients and providers, and contextual influences. METHODS This study is a cluster randomized controlled trial with 20 primary care practices (clusters) in Canada, randomized 1:1 to a PT-led or usual physician-led primary care model for LBP. Adults seeking care from their primary care team for LBP are recruited over 1 year. Data collection occurs at baseline, 6 weeks, and 3, 6, 9, and 12 months. Effectiveness will be analyzed using linear mixed regression. The process evaluation analysis will include: descriptive and comparative analyses to assess implementation; descriptive and mediation analyses to assess potential mechanisms; qualitative interpretive description to understand experiences and perspectives of patients, PTs, and other health professionals; and mixed methods to determine contextual influences on implementation. RESULTS Recruitment of primary care sites (clusters) was completed in June 2023, following delays related to the COVID-19 pandemic. Cluster randomization occurred in July 2023. Recruitment of patient participants began in October 2023 and concluded in November 2024 (n=739). The final self-reported patient data was collected on November 25, 2025. Extraction of electronic health record data is scheduled for completion on December 19, 2025. Data analysis will be conducted in accordance with the study protocol and analysis plan and will begin once all data collection activities are complete. No interim analyses have been performed. CONCLUSIONS The results of this trial will provide evidence for knowledge users to determine whether a PT-led primary care model for LBP is effective and should be adopted more widely. Knowledge users have identified the impact of the new model of care on disability, quality of life, and cost-effectiveness as key evidence needed to inform key decision-making. The multimethod process evaluation will provide critical evidence to interpret trial results and inform future scale and spread of this model of care if effective. CLINICALTRIAL ClinicalTrials.gov NCT04287413; https://clinicaltrials.gov/study/NCT04287413 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/89004
- Open Access
- 7 March 2023
- Published by CMA Impact Inc. in CMAJ Open
- Vol. 11 (2) , E227-E236
Endometriosis and cardiovascular disease: a population-based cohort study
Background: Endometriosis, a prevalent condition among females of reproductive age, may be associated with increased risk of cardiovascular disease (CVD) through chronic inflammation and early menopause. The objective of this study was to estimate the association between endometriosis and subsequent risk of CVD. Methods: We conducted a population-based cohort study using administrative health data from Ontario residents from 1993 to 2015. We compared the incidence of CVD and cardiovascular health outcomes between females with endometriosis and 2 age-matched females without endometriosis. The primary outcome was hospital admission for CVD. Secondary outcomes included in-hospital CVD events of interest and emergency department visits for CVD. We used Cox proportional hazards models to estimate adjusted hazard ratios (HRs) between endometriosis and CVD events. Results: We identified 166 835 eligible patients with endometriosis and matched 333 706 patients without endometriosis. The mean age of those with endometriosis was 36.4 years. Patients with endometriosis had a higher incidence of hospital admission for CVD (195 admissions/100 000 person-years) compared with those without endometriosis (163 admissions/100 000 person-years). Similarly, the incidence of secondary CVD events was slightly higher among patients with endometriosis (292 cases/100 000 person-years) than among those without endometriosis (224 cases/100 000 person-years). Females with endometriosis had an increased risk of hospital admission (adjusted HR 1.14, 95% confidence interval [CI] 1.10–1.19) and secondary CVD events (adjusted HR 1.26, 95% CI 1.23–1.30). Interpretation: In this large, population-based study, endometriosis was associated with a small increased risk of CVD events. Future studies need to investigate potential etiological mechanisms and strategies to decrease long-term CVD risk in patients with endometriosis.
- 7 March 2023
- Published by CMA Impact Inc. in CMAJ Open
- Vol. 11 (2) , E227-E236
Open AccessEndometriosis and cardiovascular disease: a population-based cohort study
Background: Endometriosis, a prevalent condition among females of reproductive age, may be associated with increased risk of cardiovascular disease (CVD) through chronic inflammation and early menopause. The objective of this study was to estimate the association between endometriosis and subsequent risk of CVD. Methods: We conducted a population-based cohort study using administrative health data from Ontario residents from 1993 to 2015. We compared the incidence of CVD and cardiovascular health outcomes between females with endometriosis and 2 age-matched females without endometriosis. The primary outcome was hospital admission for CVD. Secondary outcomes included in-hospital CVD events of interest and emergency department visits for CVD. We used Cox proportional hazards models to estimate adjusted hazard ratios (HRs) between endometriosis and CVD events. Results: We identified 166 835 eligible patients with endometriosis and matched 333 706 patients without endometriosis. The mean age of those with endometriosis was 36.4 years. Patients with endometriosis had a higher incidence of hospital admission for CVD (195 admissions/100 000 person-years) compared with those without endometriosis (163 admissions/100 000 person-years). Similarly, the incidence of secondary CVD events was slightly higher among patients with endometriosis (292 cases/100 000 person-years) than among those without endometriosis (224 cases/100 000 person-years). Females with endometriosis had an increased risk of hospital admission (adjusted HR 1.14, 95% confidence interval [CI] 1.10–1.19) and secondary CVD events (adjusted HR 1.26, 95% CI 1.23–1.30). Interpretation: In this large, population-based study, endometriosis was associated with a small increased risk of CVD events. Future studies need to investigate potential etiological mechanisms and strategies to decrease long-term CVD risk in patients with endometriosis.
- Open Access
- 5 August 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (8) , e38874
Variations in Care and Real World Outcomes in those with Rectal Cancer: A protocol for the Ontario Rectal Cancer Cohort (OntaReCC) (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Individuals with rectal cancer require a number of pretreatment investigations, often require multidisciplinary treatment and require ongoing follow up after treatment is completed. Due to the complexity of treatments, large variations in practice patterns and outcomes have been identified. At present, few comprehensive population level datasets are available to assess interventions and outcomes in this group. The objective of the proposed study is to create a comprehensive database of individuals treated with rectal cancer in a single payer, universal health care system. This database will provide an excellent resource for investigators to study the variations in the delivery of care, and real world outcomes in this population. Objective: The objective of this study is to create a comprehensive database to allow for assessment of the delivery of care and outcomes in those with rectal cancer Methods: The Ontario Rectal Cancer Cohort (OntaReCC) database will include comprehensive details of the management and outcomes of those with rectal cancer, diagnosed in Ontario, Canada (population 14.6 million) between 2010 – 2019. Linked administrative datasets will be used to construct this comprehensive database. Individual and care provider characteristics, investigations, treatments, follow up and outcomes will be derived and linked. Surgical pathology details, including stage of disease, histopathology characteristics and quality of surgical excision, will be included. Ethics approval for this study was obtained through Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board. A number of research themes will initially be explored using the OntaRecc Database, including (i) the regional variability in the delivery of care and outcomes, (ii) predictors and impact of adherence to recommended care, and (iii) assessments of other understudied areas of rectal cancer care. Results: Approximately 20,000 individuals were identified who meet the inclusion criteria for this study. Data analysis is ongoing, with an expected completion date of March, 2023. This study was funded through the Canadian Institute of Health Research (CIHR) Operating Grant. Conclusions: The Ontario Rectal Cancer Cohort will include a comprehensive dataset of individuals with rectal cancer who received care within a single payer, universal health care system. This cohort will be used to determine factors associated with regional variability, adherence to recommended care and allow for an assessment of a number of understudies areas within the delivery of rectal cancer treatment.
- 5 August 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (8) , e38874
Open AccessVariations in Care and Real World Outcomes in those with Rectal Cancer: A protocol for the Ontario Rectal Cancer Cohort (OntaReCC) (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Individuals with rectal cancer require a number of pretreatment investigations, often require multidisciplinary treatment and require ongoing follow up after treatment is completed. Due to the complexity of treatments, large variations in practice patterns and outcomes have been identified. At present, few comprehensive population level datasets are available to assess interventions and outcomes in this group. The objective of the proposed study is to create a comprehensive database of individuals treated with rectal cancer in a single payer, universal health care system. This database will provide an excellent resource for investigators to study the variations in the delivery of care, and real world outcomes in this population. Objective: The objective of this study is to create a comprehensive database to allow for assessment of the delivery of care and outcomes in those with rectal cancer Methods: The Ontario Rectal Cancer Cohort (OntaReCC) database will include comprehensive details of the management and outcomes of those with rectal cancer, diagnosed in Ontario, Canada (population 14.6 million) between 2010 – 2019. Linked administrative datasets will be used to construct this comprehensive database. Individual and care provider characteristics, investigations, treatments, follow up and outcomes will be derived and linked. Surgical pathology details, including stage of disease, histopathology characteristics and quality of surgical excision, will be included. Ethics approval for this study was obtained through Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board. A number of research themes will initially be explored using the OntaRecc Database, including (i) the regional variability in the delivery of care and outcomes, (ii) predictors and impact of adherence to recommended care, and (iii) assessments of other understudied areas of rectal cancer care. Results: Approximately 20,000 individuals were identified who meet the inclusion criteria for this study. Data analysis is ongoing, with an expected completion date of March, 2023. This study was funded through the Canadian Institute of Health Research (CIHR) Operating Grant. Conclusions: The Ontario Rectal Cancer Cohort will include a comprehensive dataset of individuals with rectal cancer who received care within a single payer, universal health care system. This cohort will be used to determine factors associated with regional variability, adherence to recommended care and allow for an assessment of a number of understudies areas within the delivery of rectal cancer treatment.
- 13 May 2022
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 44 (5) , 615
Reproductive Health Needs in Female Adolescent and Young Adult Survivors of Hodgkin’s Lymphoma Cancer
- 13 May 2022
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 44 (5) , 615
Reproductive Health Needs in Female Adolescent and Young Adult Survivors of Hodgkin’s Lymphoma Cancer